Nanotechnology RSS feeds


ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN

NANOTECHNOLOGY FACTS ...

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide

SALES & WANTED

nanotechnology companies | nanotechnology infoNano Silver Powder
nanotechnology companies | nanotechnology infoFree Green Engine Oil
nanotechnology companies | nanotechnology infoOxid nanopowders

-----
What have you? - Place your ads here for FREE - *APPLY*

LATEST MEMBERS

  • hrtrb_chris2pher
  • edta31
  • tvare
  • twnguyen
  • srlg
  • magdalena

WHO'S ONLINE

There are currently 0 users and 19 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

SARPU

Long description :

SARPU® series are nano-silver colloid which has an antibacterial effect against bacteria, yeasts, mould and fungi. ABC NANOTECH makes SARPU® series with a unique nanoparticle technology. Silver ion or nanoparticle of silver destroys the cell wall of the bacteria for nucleus of bacteria not to grow. This phenomenon informs us of why SARPU® series work as an antimicrobial. According to trend of antimicrobial products, consumers are pursuing both safety and effectiveness of antibacterial applications and prefer environment-friendly products. Since SARPU® series, a kind of nano-metallic antibiotic agent, provide safety and easy applicability to products and don’t give rise to any side effect, they will be a future leading antimicrobial. For example, SARPU® has already demonstrated the superiority of quality internationally. SARPU® is the first registered nano silver on the list of Oeko-Tex, International Association for Research and Testing in Field of Textile Ecology, located in Switzerland.

Product's company name : ABC NANOTECH Co., Ltd

Product company Url :
http://www.abcnanotech.com
» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page